"We continue to work with NRC on the production of our COVID-19 vaccine and manufacturing of process performance qualification batches is expected to begin in early 2023," said the company's spokesperson.Ī spokesperson for Industry Minister François-Philippe Champagne said the government "will continue to monitor the situation regarding Novavax" and suggested the NRC site could be used to manufacture other vaccines from different companies. In a statement, the company said it will press ahead. In an interview with Reuters after announcing the financial results, the company's CEO said the company has been spending at a "hot rate," and it plans to cut back - including possible job cuts.ĬBC News asked Novavax if it plans to continue its work with the NRC given the state of the company's finances. The Maryland-based company has warned it may run out of cash. WATCH: Canada still without vaccine plant despite federal promisesĪ vial of the Phase 3 Novavax coronavirus vaccine is seen in this file photo. While the biologics centre is built and Health Canada has authorized the Novavax shot for use in Canada, the NRC site still isn't producing vaccines at scale - the complex regulatory and scientific process hasn't been completed on the government's ambitious timeline. company's COVID-19 shot by "mid-2021." The plan was billed as a way to lessen Canada's dependence on foreign sources of shots.Īs CBC News has previously reported, the NRC plant still hasn't produced a single vial of the Novavax vaccine. Then, in early 2021, Trudeau announced the partnership with Novavax, saying the NRC's biologics manufacturing centre would churn out the U.S. That never happened after a plan to work with CanSino fell through. Prime Minister Justin Trudeau said in 2020, at the height of the pandemic, that the country would produce Canadian-made shots at a new purpose-built facility at Royalmount by the end of that year. The government has long promised it will produce Novavax's COVID-19 vaccine at the National Research Council (NRC) Royalmount site in Montreal - a publicly owned facility in a country that has seen vaccine production all but disappear after decades of mismanagement and changing economics. Two years after Trudeau promised a made-in-Canada COVID vaccine, the country is still waiting.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |